Therapy Analysis & Statistics, June 2014 (p20)

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

All regions

You might be interested in: therapeutics, biotherapeutics, cancer therapeutics, more »

571-600 of about 2 200 reports

Purchase Reports From Reputable Market Research Publishers

Physician Views: What does the future hold for new EGFR targeting NSCLC therapies?

Physician Views: What does the future hold for new EGFR targeting NSCLC therapies?

  • $ 645
  • Industry report
  • June 2014
  • by Firstword Pharma

Propelled via momentum from new data presented at the ASCO annual meeting, AstraZeneca's AZD-9291 and Clovis Oncology's CO-1686 look poised to advance the treatment paradigm for EGFR-positive non-small-cell ...

  • Industries : Therapy
BIND Therapeutics, Inc. (formerly BIND Biosciences, Inc.) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

BIND Therapeutics, Inc. (formerly BIND Biosciences, Inc.) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • June 2014
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Therapy
United Therapeutics Corporation - Strategy and SWOT Report

United Therapeutics Corporation - Strategy and SWOT Report

  • $ 175
  • Company report
  • June 2014
  • by MarketLine

United Therapeutics Corporation - SWOT Analysis company profile is the essential source for top-level company data and information. United Therapeutics Corporation - SWOT Analysis examines the company's ...

  • Industries : Therapy
  • Countries : United States
AnGes MG, Inc. (Symbol:4563) SWOT Analysis, Strategy, Revenues and Profits

AnGes MG, Inc. (Symbol:4563) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • June 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Therapy
Mirna Therapeutics, Inc. - Product Pipeline Review - 2014

Mirna Therapeutics, Inc. - Product Pipeline Review - 2014

  • $ 1 500
  • Company report
  • June 2014
  • by Global Markets Direct

Mirna Therapeutics, Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct's, ‘Mirna Therapeutics, Inc. - Product Pipeline Review - 2014', provides an overview of the Mirna Therapeutics, ...

  • Industries : Therapy
  • Countries : World
Flexion Therapeutics, Inc. - Product Pipeline Review - 2014

Flexion Therapeutics, Inc. - Product Pipeline Review - 2014

  • $ 1 500
  • Company report
  • June 2014
  • by Global Markets Direct

Flexion Therapeutics, Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct's, ‘Flexion Therapeutics, Inc. - Product Pipeline Review - 2014', provides an overview of the Flexion Therapeutics, ...

  • Industries : Therapy
  • Countries : World
Regulus Therapeutics Inc. - Product Pipeline Review - 2014

Regulus Therapeutics Inc. - Product Pipeline Review - 2014

  • $ 1 500
  • Company report
  • June 2014
  • by Global Markets Direct

Regulus Therapeutics Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct's, ‘Regulus Therapeutics Inc. - Product Pipeline Review - 2014', provides an overview of the Regulus Therapeutics ...

  • Industries : Therapy
  • Countries : World
Arno Therapeutics, Inc. (ARNI) - Financial and Strategic SWOT Analysis Review

Arno Therapeutics, Inc. (ARNI) - Financial and Strategic SWOT Analysis Review

  • $ 125
  • Company report
  • June 2014
  • by Global Data

Arno Therapeutics, Inc. (ARNI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled ...

  • Industries : Therapy
  • Countries : United States
Sarepta Therapeutics, Inc. (SRPT) - Financial and Strategic SWOT Analysis Review

Sarepta Therapeutics, Inc. (SRPT) - Financial and Strategic SWOT Analysis Review

  • $ 125
  • Company report
  • June 2014
  • by Global Data

Sarepta Therapeutics, Inc. (SRPT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled ...

  • Industries : Therapy
Physiotherapy Services Market in Australia

Physiotherapy Services Market in Australia

  • $ 965
  • Industry report
  • June 2014
  • by Ibisworld

IBISWORLD This is the replacement for IBISWorld's October Physiotherapy Services in Australia About this Market This market research report from IBISWorld provides a in-depth overview of the Physiotherapy ...

  • Industries : Therapy
  • Countries : Australia
Kinase Inhibitors for Treating Cancer: Industry Analysis, R&D Trends and World Market Forecasts 2014-2024

Kinase Inhibitors for Treating Cancer: Industry Analysis, R&D Trends and World Market Forecasts 2014-2024

  • $ 3 013
  • Industry report
  • June 2014
  • by Visiongain

Report Details Kinase inhibitors - a new study showing you trends, R&D and predicted revenues Do you want to find sales potentials of kinase inhibitors? Now get the latest analysis for those cancer treatments. ...

  • Industries : Therapy
  • Countries : World
Kinase Inhibitors for Treating Cancer: Industry Analysis, R&D Trends and World Market Forecasts 2014-2024

Kinase Inhibitors for Treating Cancer: Industry Analysis, R&D Trends and World Market Forecasts 2014-2024

  • $ 3 013
  • Industry report
  • June 2014
  • by Visiongain

Report Details Kinase inhibitors - a new study showing you trends, R&D and predicted revenues Do you want to find sales potentials of kinase inhibitors? Now get the latest analysis for those cancer treatments. ...

  • Industries : Therapy
  • Countries : World
Kinase Inhibitors for Treating Cancer: Industry Analysis, R&D Trends and World Market Forecasts 2014-2024

Kinase Inhibitors for Treating Cancer: Industry Analysis, R&D Trends and World Market Forecasts 2014-2024

  • $ 3 013
  • Industry report
  • June 2014
  • by Visiongain

Report Details Kinase inhibitors - a new study showing you trends, R&D and predicted revenues Do you want to find sales potentials of kinase inhibitors? Now get the latest analysis for those cancer treatments. ...

  • Industries : Therapy
  • Countries : World
Targacept, Inc. (Symbol:TRGT) SWOT Analysis, Strategy, Revenues and Profits

Targacept, Inc. (Symbol:TRGT) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • June 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Therapy
U.S. Physical Therapy, Inc. (Symbol:USPH) SWOT Analysis, Strategy, Revenues and Profits

U.S. Physical Therapy, Inc. (Symbol:USPH) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • June 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Therapy
  • Countries : United States
Cellectar Biosciences, Inc. (CLRB) - Financial and Strategic SWOT Analysis Review

Cellectar Biosciences, Inc. (CLRB) - Financial and Strategic SWOT Analysis Review

  • $ 125
  • Company report
  • June 2014
  • by Global Data

Cellectar Biosciences, Inc. (CLRB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled ...

  • Industries : Therapy
Inhaled COPD Therapeutics Market

Inhaled COPD Therapeutics Market

  • $ 3 850
  • Industry report
  • June 2014
  • by Greystone Research Associates

COPD is not one but a family of conditions, each with its own etiology and treatment challenges. Chronic bronchitis is the inflammation and eventual scarring of the lining of the bronchial tubes. Oral ...

  • Industries : Therapy
Inhaled Asthma Therapeutics Market

Inhaled Asthma Therapeutics Market

  • $ 3 850
  • Industry report
  • June 2014
  • by Greystone Research Associates

Asthma continues to be a health segment with significant incidence and morbidity. There has been significant interest directed toward the development easier-to-use inhalers, primarily because a large segment ...

  • Industries : Therapy
Inhaled CNS Therapeutics Market

Inhaled CNS Therapeutics Market

  • $ 2 850
  • Industry report
  • June 2014
  • by Greystone Research Associates

Neurological disorders are highly prevalent worldwide. And while mental and neurological disorders are responsible for about one per cent of deaths, they account for almost 11 per cent of disease burden ...

  • Industries : Therapy
Breast Cancer Therapeutics in Major Developed Markets to 2020 - Approval of Novel Therapies to Support Continued Dominance of HER2 Targeted Drugs

Breast Cancer Therapeutics in Major Developed Markets to 2020 - Approval of Novel Therapies to Support Continued Dominance of HER2 Targeted Drugs

  • $ 3 500
  • Industry report
  • June 2014
  • by GBI Research

Breast Cancer Therapeutics in Major Developed Markets to 2020 - Approval of Novel Therapies to Support Continued Dominance of HER2 Targeted Drugs Summary GBI Research, the leading business intelligence ...

  • Industries : Therapy
  • Countries : World
Antihypertensive Therapeutics in Major Developed Markets to 2020 - Increased Uptake of Combination Therapies to Offset Effects of Key Patent Expiries

Antihypertensive Therapeutics in Major Developed Markets to 2020 - Increased Uptake of Combination Therapies to Offset Effects of Key Patent Expiries

  • $ 3 500
  • Industry report
  • June 2014
  • by GBI Research

Antihypertensive Therapeutics in Major Developed Markets to 2020 - Increased Uptake of Combination Therapies to Offset Effects of Key Patent Expiries Summary GBI Research, the leading business intelligence ...

  • Industries : Therapy
  • Countries : World
Glioblastoma Multiforme Therapeutics in Major Developed Markets to 2019 - Growth to Hinge on the Success of Personalized Vaccine Following Early Approval in Germany

Glioblastoma Multiforme Therapeutics in Major Developed Markets to 2019 - Growth to Hinge on the Success of Personalized Vaccine Following Early Approval in Germany

  • $ 3 500
  • Industry report
  • June 2014
  • by GBI Research

Glioblastoma Multiforme Therapeutics in Major Developed Markets to 2019 - Growth to Hinge on the Success of Personalized Vaccine Following Early Approval in Germany Summary GBI Research, a leading business ...

  • Industries : Therapy
  • Countries : World, Germany, Japan, United States, Europe, North America, Canada, Spain, Italy, France, United Kingdom
Global Proton Therapy Outlook 2018

Global Proton Therapy Outlook 2018

  • $ 2 000
  • Industry report
  • June 2014
  • by RNCOS

Proton Therapy, the new kid on the block for cancer treatment, has garnered worldwide attention in the past few years. Due to its ability to deliver higher doses of radiation to the targeted areas without ...

  • Industries : Therapy
  • Countries : Germany, China, Japan, World
 Uveitis- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

Uveitis- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

  • $ 2 000
  • Industry report
  • June 2014
  • by Delve Insight

DelveInsight's, “ Uveitis- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights about phase III pipeline drugs and marketed drugs ...

  • Industries : Therapy
  • Countries : United States, World
 Women Infertility- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

Women Infertility- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

  • $ 2 000
  • Industry report
  • June 2014
  • by Delve Insight

DelveInsight's, “ Women Infertility- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights about phase III pipeline drugs and marketed ...

  • Industries : Therapy
  • Countries : United States, World
 Malaria- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

Malaria- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

  • $ 2 000
  • Industry report
  • June 2014
  • by Delve Insight

DelveInsight's, “ Malaria- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights about phase III pipeline drugs and marketed drugs ...

  • Industries : Therapy
  • Countries : United States, World
 Anthrax- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

Anthrax- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

  • $ 2 000
  • Industry report
  • June 2014
  • by Delve Insight

DelveInsight's, “ Anthrax- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights about phase III pipeline drugs and marketed drugs ...

  • Industries : Therapy
  • Countries : United States, World
 Genital Herpes- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

Genital Herpes- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

  • $ 2 000
  • Industry report
  • June 2014
  • by Delve Insight

DelveInsight's, “ Genital Herpes- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights about phase III pipeline drugs and marketed ...

  • Industries : Therapy
  • Countries : United States, World
 Inflammation- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

Inflammation- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

  • $ 2 000
  • Industry report
  • June 2014
  • by Delve Insight

DelveInsight's, “ Inflammation- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights about phase III pipeline drugs and marketed ...

  • Industries : Therapy
  • Countries : United States, World
 Mania- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

Mania- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

  • $ 2 000
  • Industry report
  • June 2014
  • by Delve Insight

DelveInsight's, “ Mania- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights about phase III pipeline drugs and marketed drugs ...

  • Industries : Therapy
  • Countries : United States, World
About 700 reports

Download Unlimited Documents from Trusted Public Sources

Drug And Medication Markets in India

  • October 2014
    22 pages
  • Drug And Medica...  

    Pharmaceutical  

    Therapy  

  • India  

View report >

Therapy Markets In The Us

September 2014

Vaccine Supply In Europe

September 2014

43 Companies

Read our Company Profiles

GlaxoSmithKline P.L.C.

United States

Johnson and Johnson

United States

Biogen Idec

United States

Merck KGaA

Germany

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.